Difference between revisions of "LncRNAWiki:O"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''OIP5-AS1'' |ENST00000500949.2 |cyrano,LOC729082, linc-NU...") |
|||
| Line 1: | Line 1: | ||
| + | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
| + | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
| + | </div> | ||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
| Line 5: | Line 8: | ||
!Alias | !Alias | ||
!Description | !Description | ||
| + | !Disease | ||
|- | |- | ||
|''OIP5-AS1'' | |''OIP5-AS1'' | ||
|[[ENST00000500949.2]] | |[[ENST00000500949.2]] | ||
| − | |cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1 | + | |"cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1" |
|OIP5 antisense RNA 1 | |OIP5 antisense RNA 1 | ||
| + | |_ | ||
|- | |- | ||
|''OLMALINC'' | |''OLMALINC'' | ||
|[[OLMALINC]] | |[[OLMALINC]] | ||
| − | |bA34D15.5, FLJ12974, HI-LNC80 | + | |"bA34D15.5, FLJ12974, HI-LNC80" |
|oligodendrocyte maturation-associated long intergenic non-coding RNA | |oligodendrocyte maturation-associated long intergenic non-coding RNA | ||
| + | |_ | ||
|- | |- | ||
|''OTX2-AS1'' | |''OTX2-AS1'' | ||
|[[lnc-C14orf101-5:1]] | |[[lnc-C14orf101-5:1]] | ||
| − | |OTX2OS1, ENSG00000248550 | + | |"OTX2OS1, ENSG00000248550" |
|OTX2 antisense RNA 1 (head to head) | |OTX2 antisense RNA 1 (head to head) | ||
| + | |_ | ||
|- | |- | ||
|''OVAAL'' | |''OVAAL'' | ||
|[[ENST00000442621.1]] | |[[ENST00000442621.1]] | ||
| − | |LINC01131,OVAL | + | |"LINC01131,OVAL" |
|ovarian adenocarcinoma amplified long non-coding RNA | |ovarian adenocarcinoma amplified long non-coding RNA | ||
| + | |ovarian cancer | ||
| + | |- | ||
|} | |} | ||
Revision as of 11:39, 30 June 2016
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| OIP5-AS1 | ENST00000500949.2 | "cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1" | OIP5 antisense RNA 1 | _ |
| OLMALINC | OLMALINC | "bA34D15.5, FLJ12974, HI-LNC80" | oligodendrocyte maturation-associated long intergenic non-coding RNA | _ |
| OTX2-AS1 | lnc-C14orf101-5:1 | "OTX2OS1, ENSG00000248550" | OTX2 antisense RNA 1 (head to head) | _ |
| OVAAL | ENST00000442621.1 | "LINC01131,OVAL" | ovarian adenocarcinoma amplified long non-coding RNA | ovarian cancer |
